Counseling Patients on the Use of Pharmacotherapy for Insomnia Please read through the following information and click Continue.
ACPE Universal Program Number: 0207-0000-16-007-H01-P;0207-0000-16-007-H01-T Release Date: July 1, 2016 Expiration Date: July 1, 2019 Activity Type: Application-based
Statement of Need Disturbed sleep may be one of the most common, yet inadequately treated, health conditions shared by people across the globe. Nearly 70 million people across the United States have a diagnosed sleep disorder, and approximately 50 percent of U.S. adults each year report having trouble sleeping. Insomnia can be defined simply as the inability to sleep, but many complexities hide in that definition. Sleeping difficulties affect people of all types and ages; they may be an acute reaction to an identifiable cause or can develop into a chronic concern that contributes to accumulated sleep debt—the difference between how much sleep is recommended and how much actually takes place. Personal and socioeconomic costs of insomnia develop from lost work productivity, accidents, and increased physician and pharmacy visits. Despite the clear adverse effects of poor sleep, the causes and progression of insomnia make it continually difficult to treat successfully. The July continuing education article describes ways for pharmacists to help patients with this condition.
Pharmacists Learning Objectives Upon successful completion of this activity, pharmacists should be better able to:
Pharmacy Technicians Learning Objectives Upon successful completion of this activity, pharmacy technicians should be better able to:
Any medications or treatment methods suggested in this activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication. This article contains a discussion of off-label uses that will be identified as such by the author.
Target Audience The target audience for this activity is Pharmacists and Pharmacy Technicians.
Instructions for Participation To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee There is no fee for this activity.
Faculty Nicole Van Hoey, PharmD, is a freelance medical writer and editor in Arlington, Va.
Disclosure Declaration It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.
The authors, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Commercial Support Supported by an independent education grant from Merck.
MAC Safari (Latest Version) Firefox (Latest Version) *Adobe Acrobat Reader